Related Experiment Video
Updated: Aug 13, 2026
10:10
Long-term Culture of Human Breast Cancer Specimens and Their Analysis Using Optical Projection Tomography
Published on: July 29, 2011
2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond
1Department of Pathology, Singapore General Hospital, Outram Road, Singapore 169608. gpttph@sgh.com.sg
Annals of the Academy of Medicine, Singapore
|February 3, 2006
Summary
This study found that involved surgical margins are key for breast phyllodes tumour (PT) prognosis. CD117 expression predicts recurrence, suggesting potential therapeutic targets for this rare breast cancer.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- This study investigated breast phyllodes tumours (PTs) in Asian women, focusing on morphological and immunohistochemical predictors of prognosis.
- It evaluated the role of p53 and CD117 expression in the stromal component of PTs.
Discussion:
- Morphological classification and surgical margin status are critical prognostic factors for PTs.
- Immunohistochemical markers, particularly CD117, show promise in predicting recurrence risk.
- p53 expression can aid in corroborating malignancy in PTs.
Key Insights:
- Complete surgical margins significantly reduce the risk of PT recurrence.
- CD117 immunoexpression is a significant predictor of PT recurrence.
- p53 and CD117 mRNA upregulation correlates with protein overexpression, validating molecular findings.
Outlook:
- Further validation of CD117 as a therapeutic target for PTs is warranted.
- Aggressive management strategies should be considered for malignant PTs presenting at diagnosis.
- Continued research into molecular markers may improve PT patient outcomes.
